Bank of Montreal
OVID icon

Bank of Montreal’s Ovid Therapeutics OVID Stock Holding History

Bank of Montreal’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,333
Closed -$5K – 4579
2021
Q1 		$5K Sell
1,333
-6,245
-82% -$20.7K ﹤0.01% 4656
2020
Q4 		$19K Buy
7,578
+5,606
+284% +$26.1K ﹤0.01% 4439
2020
Q3 		$12K Sell
1,972
-1,445
-42% -$9.67K ﹤0.01% 4063
2020
Q2 		$27K Buy
+3,417
New +$16K ﹤0.01% 3718
2019
Q3 		– Sell
-31
Closed – – 4917
2019
Q2 		$0 Buy
31
+25
+417% +$45 ﹤0.01% 5022
2019
Q1 		$0 Sell
6
-182
-97% -$455 ﹤0.01% 4622
2018
Q4 		$0 Buy
188
+97
+107% +$443 ﹤0.01% 4800
2018
Q3 		$1K Sell
91
-3
-3% -$23 ﹤0.01% 4575
2018
Q2 		$1K Buy
+94
New +$807 ﹤0.01% 4564

Other funds holding OVID

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's OVID Position: Q2 2021 in Review

Bank of Montreal sold out of Ovid Therapeutics (OVID) in Q2 2021, closing a stake of 1,333 shares — an estimated $5K sold.

Bank of Montreal first reported a position in OVID in Q2 2018 and held it in 9 quarters. The position peaked at $27K in Q2 2020. 80 funds tracked by Wall St. Rank hold OVID as of Q2 2021.

  • Bank of Montreal reported no remaining Ovid Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 1,333 Ovid Therapeutics shares in Q2 2021, an estimated $5K.
  • Bank of Montreal first reported a position in Ovid Therapeutics in Q2 2018 and held it in 9 quarters.
  • Bank of Montreal's Ovid Therapeutics position peaked at $27K in Q2 2020.
  • 80 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.